Network origin in Anders Lilja first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 21 | |
Batavia Biosciences BV
 Batavia Biosciences BV Pharmaceuticals: MajorHealth Technology Batavia Biosciences BV provides biopharmaceutical process development services. It offers biopharmaceutical materials research and pre-clinical study services for biopharmaceutical clients. The firm services cover candidate selection, production of research materials, upstream and downstream process development, assay development, product characterization and clinical manufacturing and release. The company was founded in 2010 and is headquartered in Leiden, the Netherlands.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Anders Lilja via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member Chief Executive Officer Chairman Director/Board Member Director/Board Member Founder Director/Board Member | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
GeneSpire Srl
 GeneSpire Srl BiotechnologyHealth Technology GeneSpire Srl is a holding company, which engages in the development of transformative gene therapies for patients with genetic diseases. The company was founded by Luigi Naldini and Alessio Cantone in March 2020 and is headquartered in Milan, Italy. | Biotechnology | Chairman Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| UNIQURE N.V. | Biotechnology | Chief Executive Officer Founder | |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Geneva | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| Gilead Sciences Ireland UC | Chief Operating Officer | ||
Janssen Biologics BV
 Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ICON PUBLIC LIMITED COMPANY | Miscellaneous Commercial Services | Director/Board Member | |
| Baltimore Bays Soccer Club | Corporate Officer/Principal | ||
MOMA Therapeutics, Inc.
 MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| The Johns Hopkins University | College/University | Masters Business Admin | |
IDRx, Inc.
 IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
National Institute for Bioprocessing Research & Training
 National Institute for Bioprocessing Research & Training BiotechnologyHealth Technology The National Institute for Bioprocessing Research & Training (NIBRT) is a center of excellence for training and research in biopharmaceutical manufacturing. NIBRT operates in a world-class facility in Ireland, purpose-built to closely replicate a modern bioprocessing plant with state-of-the-art equipment. NIBRT offers the highest quality training and research solutions to support the growth and development of the biopharma manufacturing industry. | Biotechnology | Director/Board Member | |
| Rijksinstituut Voor Volksgezondheid En Milieu | Corporate Officer/Principal | ||
| Trinity College Dublin | College/University | Undergraduate Degree | |
| Fondation Mérieux | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Alexion Pharma International Operations Ltd.
 Alexion Pharma International Operations Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Alexion Pharma International Operations Ltd. wholesales drugs, proprietaries and sundries. The company is based in Dublin, Ireland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
American Chamber of Commerce Ireland
 American Chamber of Commerce Ireland Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce Ireland is a leading international business organization that supports the Transatlantic business relationship. The non-profit company is based in Dublin, Ireland. The Irish company provides networking opportunities, leadership development programs, and representation to government, media, and stakeholders. The company's highly sought-after programs operate virtually and in person, supporting individual growth within their member companies. The CEO of the company is Mark Redmond. | Miscellaneous Commercial Services | Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| National Standards Authority of Ireland | Chairman | ||
| University College Cork | College/University | Corporate Officer/Principal | |
| RELAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Thrive Earlier Detection Corp.
 Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Medical Specialties | Founder | |
| University of Zurich Medical School | College/University | Undergraduate Degree | |
| University of Vienna | College/University | Graduate Degree | |
| University of Natural Resources & Life Sciences | College/University | Doctorate Degree | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
Takeda Manufacturing Austria AG
 Takeda Manufacturing Austria AG Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Manufacturing Austria AG manufactures and supplies vital medicines and medical devices. The company is based in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
Austrian Academy of Sciences
 Austrian Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Austrian Academy of Sciences provides humanities and social science research services. The private company is based in Vienna, Austria. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Boehringer AG
 Boehringer AG Pharmaceuticals: MajorHealth Technology Boehringer AG is an investment holding German company that owns subsidiaries which manufacture pharmaceutical products. The private company is based in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Shire Austria GmbH
 Shire Austria GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Austria GmbH develops and manufactures pharmaceutical products. The company is based in Donau, Austria. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Basel | College/University | Corporate Officer/Principal | |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
The Sidney Kimmel Comprehensive Cancer Center
 The Sidney Kimmel Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services The Sidney Kimmel Comprehensive Cancer Center offers immune-based treatments for cancer. The company was founded by Sidney Kimmel in 1973 and is headquartered in Baltimore, MD. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Universität Salzburg | College/University | Graduate Degree | |
Presage Biosciences, Inc.
 Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Institute of Directors In Ireland
 Institute of Directors In Ireland Miscellaneous Commercial ServicesCommercial Services Institute of Directors In Ireland promotes governance and develops leadership skills. It offer services to boards in Ireland including a non-executive director and chairperson appointment service through the boardroom centre, a board evaluation service, carried out by highly experienced assessors. The company is headquartered in Dublin, Ireland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ILC Dover LP
 ILC Dover LP Pharmaceuticals: MajorHealth Technology ILC Dover LP operates as an engineering development and manufacturing company, which specializes in the use of flexible materials, serving the aerospace, personal protection, and pharmaceutical industries. Its products include lighter-than-air structures, personal protection equipment, engineered inflatables, powder containment, industrial containment, space suites, space inflatables, and specialty materials. The company was founded in 1947 and is headquartered in Federica, DE. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 18 |
| Ireland | 11 |
| Austria | 9 |
| Netherlands | 5 |
| Switzerland | 4 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 11 |
| Commercial Services | 9 |
| Finance | 3 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 85 |
| Corporate Officer/Principal | 58 |
| Independent Dir/Board Member | 19 |
| Chief Tech/Sci/R&D Officer | 16 |
| Director of Finance/CFO | 13 |
Most connected contacts
| Insiders | |
|---|---|
| Graziano Seghezzi | 26 |
| Michael Kelly | 19 |
| Sander J. van Deventer | 17 |
| Christoph S. Lengauer | 16 |
| Julie O'Neill | 16 |
| Jan van de Winkel | 15 |
| Jörn Aldag | 15 |
| Victor Paulus | 12 |
| David Kaufman | 10 |
| Matthew Beck | 10 |
| Jean-Charles Soria | 10 |
| Reinhard Kandera | 10 |
| Roman Necina | 9 |
| Christine Baker | 9 |
| Igor Matushansky | 7 |
- Stock Market
- Insiders
- Anders Lilja
- Company connections
